Epion Therapeutics

Burlington, United States

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

$32.0M raised

Sep 2022

Series A

Biotechnology Health Care Life Science Personal Health Pharmaceutical

Top Investors

Global Health Investment Fund (GHIF)

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Epion Therapeutics

How much funding has Epion Therapeutics raised?

Epion Therapeutics has raised $32.0M in total funding. The most recent round was Series A. The last funding was announced in September 2022.

Who are Epion Therapeutics's investors?

Epion Therapeutics's investors include Global Health Investment Fund (GHIF).

Where is Epion Therapeutics headquartered?

Epion Therapeutics is headquartered in Burlington, United States.

What does Epion Therapeutics do?

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

What stage is Epion Therapeutics at?

Epion Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 30, 2022.

MLA

"Epion Therapeutics — Funding & Investors." VCBacked, September 30, 2022, https://www.vcbacked.co/company/epion-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Epion Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/epion-therapeutics

Wikipedia (cite web)

{{cite web |title=Epion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/epion-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 30, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K